P W Armstrong. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseAngina, Unstable/drug therapyAnticoagulants/administration & dosageAnticoagulants/adverse effectsAnticoagulants/therapeutic useClinical Trials as TopicCoronary Disease/drug therapyEnoxaparin/administration & dosageEnoxaparin/adverse effectsEnoxaparin/therapeutic useFibrinolytic Agents/administration & dosageFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHemorrhage/chemically inducedHeparin, Low-Molecular-Weight/therapeutic useHospitalizationHumansInjections, SubcutaneousMeta-Analysis as TopicMyocardial Infarction/prevention & controlRecurrenceThrombolytic TherapyTreatment Outcome
Substances: See more » AnticoagulantsEnoxaparinFibrinolytic AgentsHeparin, Low-Molecular-Weight
Year: 1999 PMID: 10517727 DOI: 10.1161/01.cir.100.15.1586
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690